ResMed Historical Balance Sheet

RMD Stock  USD 198.03  1.70  0.87%   
Trend analysis of ResMed Inc balance sheet accounts such as Total Stockholder Equity of 5 B, Property Plant And Equipment Net of 804 M, Net Debt of 1.6 B or Retained Earnings of 5.1 B provides information on ResMed's total assets, liabilities, and equity, which is the actual value of ResMed Inc to its prevalent stockholders. By breaking down trends over time using ResMed balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.
 
Dot-com Bubble
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Financial Statement Analysis is much more than just reviewing and examining ResMed Inc latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether ResMed Inc is a good buy for the upcoming year.

ResMed Inventory

1.21 Billion

  
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in ResMed Inc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in population.

About ResMed Balance Sheet Analysis

Balance Sheet is a snapshot of the financial position of ResMed Inc at a specified time, usually calculated after every quarter, six months, or one year. ResMed Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of ResMed and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which ResMed currently owns. An asset can also be divided into two categories, current and non-current.

ResMed Balance Sheet Chart

ResMed Balance Sheet is one of the main financial statements that report all assets, liabilities, and shareholders' equity for the current year. It provides a basis for different types of computing rates of return, such as return on equity (ROE) or return on asset (ROA), as well as shows how ResMed Inc uses and utilizes its capital. It also shows what exactly a company owns and owes.
At present, ResMed's Short and Long Term Debt Total is projected to increase significantly based on the last few years of reporting. The current year's Other Current Liabilities is expected to grow to about 528.7 M, whereas Accumulated Other Comprehensive Income is projected to grow to (233 M).

Total Assets

Total assets refers to the total amount of ResMed assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in ResMed Inc books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.

Total Current Liabilities

Total Current Liabilities is an item on ResMed balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of ResMed Inc are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.

Property Plant And Equipment Net

The total value of a company's physical assets (such as land, buildings, and equipment) used in operations, net of depreciation. It reflects the company's investment in assets used for production.
Most accounts from ResMed's balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into ResMed Inc current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in ResMed Inc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in population.
At present, ResMed's Short and Long Term Debt Total is projected to increase significantly based on the last few years of reporting. The current year's Other Current Liabilities is expected to grow to about 528.7 M, whereas Accumulated Other Comprehensive Income is projected to grow to (233 M).
 2021 2022 2023 2024 (projected)
Short and Long Term Debt Total917.6M1.6B1.8B1.9B
Total Assets5.1B6.8B7.8B8.2B

ResMed balance sheet Correlations

0.910.810.880.980.930.870.990.96-0.330.980.92-0.320.970.60.940.960.940.650.970.91-0.170.930.930.420.69
0.910.630.770.840.760.920.860.85-0.280.920.77-0.280.840.480.980.840.780.490.970.780.00.950.760.330.65
0.810.630.90.80.780.720.790.82-0.510.850.83-0.510.820.470.680.740.740.630.780.61-0.360.80.780.350.72
0.880.770.90.850.860.740.870.88-0.270.870.8-0.270.890.630.750.780.770.50.860.760.040.830.860.50.6
0.980.840.80.850.960.790.990.94-0.280.950.91-0.280.970.620.870.970.970.690.910.94-0.190.860.960.430.64
0.930.760.780.860.960.650.940.93-0.070.870.79-0.070.940.770.780.880.890.590.840.96-0.120.771.00.590.52
0.870.920.720.740.790.650.820.8-0.620.930.86-0.620.80.250.950.840.780.610.940.62-0.230.970.650.120.82
0.990.860.790.870.990.940.820.97-0.30.960.92-0.290.980.640.90.960.950.610.940.92-0.150.890.940.460.63
0.960.850.820.880.940.930.80.97-0.280.940.86-0.280.960.670.880.890.870.520.930.87-0.180.890.930.530.66
-0.33-0.28-0.51-0.27-0.28-0.07-0.62-0.3-0.28-0.47-0.571.0-0.280.34-0.38-0.4-0.35-0.52-0.370.060.59-0.49-0.070.36-0.72
0.980.920.850.870.950.870.930.960.94-0.470.94-0.470.950.510.950.940.910.670.980.82-0.240.970.870.340.76
0.920.770.830.80.910.790.860.920.86-0.570.94-0.570.910.440.850.910.890.660.880.74-0.320.880.790.270.67
-0.32-0.28-0.51-0.27-0.28-0.07-0.62-0.29-0.281.0-0.47-0.57-0.270.34-0.38-0.4-0.35-0.52-0.370.060.59-0.49-0.070.36-0.72
0.970.840.820.890.970.940.80.980.96-0.280.950.91-0.270.70.880.910.90.540.930.9-0.150.890.940.530.6
0.60.480.470.630.620.770.250.640.670.340.510.440.340.70.460.460.470.060.530.740.130.450.770.940.08
0.940.980.680.750.870.780.950.90.88-0.380.950.85-0.380.880.460.880.830.550.980.78-0.170.970.780.310.71
0.960.840.740.780.970.880.840.960.89-0.40.940.91-0.40.910.460.880.990.770.90.89-0.240.860.880.260.7
0.940.780.740.770.970.890.780.950.87-0.350.910.89-0.350.90.470.830.990.770.860.9-0.230.80.90.270.67
0.650.490.630.50.690.590.610.610.52-0.520.670.66-0.520.540.060.550.770.770.570.54-0.450.560.59-0.110.75
0.970.970.780.860.910.840.940.940.93-0.370.980.88-0.370.930.530.980.90.860.570.82-0.120.990.840.380.72
0.910.780.610.760.940.960.620.920.870.060.820.740.060.90.740.780.890.90.540.820.030.720.960.540.41
-0.170.0-0.360.04-0.19-0.12-0.23-0.15-0.180.59-0.24-0.320.59-0.150.13-0.17-0.24-0.23-0.45-0.120.03-0.2-0.120.16-0.49
0.930.950.80.830.860.770.970.890.89-0.490.970.88-0.490.890.450.970.860.80.560.990.72-0.20.770.310.77
0.930.760.780.860.961.00.650.940.93-0.070.870.79-0.070.940.770.780.880.90.590.840.96-0.120.770.590.53
0.420.330.350.50.430.590.120.460.530.360.340.270.360.530.940.310.260.27-0.110.380.540.160.310.590.04
0.690.650.720.60.640.520.820.630.66-0.720.760.67-0.720.60.080.710.70.670.750.720.41-0.490.770.530.04
Click cells to compare fundamentals

ResMed Account Relationship Matchups

ResMed balance sheet Accounts

201920202021202220232024 (projected)
Total Assets4.6B4.7B5.1B6.8B7.8B8.2B
Short Long Term Debt Total1.3B793.7M917.6M1.6B1.8B1.9B
Other Current Liab335.1M628.6M389.6M437.9M503.6M528.7M
Total Current Liabilities602.8M911.8M689.3M758.5M872.3M915.9M
Total Stockholder Equity2.5B2.9B3.4B4.1B4.7B5.0B
Property Plant And Equipment Net535.7M592.1M630.5M665.8M765.7M804.0M
Net Debt836.1M498.4M643.8M1.4B1.6B1.6B
Retained Earnings2.8B3.1B3.6B4.3B4.9B5.1B
Accounts Payable135.8M138.0M159.2M150.8M173.4M182.0M
Cash463.2M295.3M273.7M227.9M262.1M335.8M
Non Current Assets Total3.1B3.2B3.2B4.4B5.0B5.3B
Non Currrent Assets Other189.7M240.8M251.5M395.4M454.7M477.5M
Cash And Short Term Investments463.2M295.3M273.7M227.9M262.1M340.4M
Net Receivables474.6M614.3M576.0M704.9M810.6M851.2M
Common Stock Shares Outstanding145.7M146.5M147.0M147.6M169.7M147.3M
Liabilities And Stockholders Equity4.6B4.7B5.1B6.8B7.8B8.2B
Non Current Liabilities Total1.5B930.7M1.0B1.9B2.1B2.2B
Inventory416.9M457.0M743.9M998.0M1.1B1.2B
Other Current Assets168.7M208.2M337.9M437.0M502.6M527.7M
Other Stockholder Equity(52.6M)(1.1M)59.2M148.8M133.9M140.6M
Total Liab2.1B1.8B1.7B2.6B3.0B3.2B
Total Current Assets1.5B1.6B1.9B2.4B2.7B2.9B
Short Term Debt33.3M35.6M31.8M31.8M36.6M66.7M
Intangible Assets448.2M392.6M345.9M552.3M635.2M667.0M
Property Plant And Equipment Gross535.7M592.1M630.5M665.8M765.7M804.0M
Accumulated Other Comprehensive Income(284.0M)(193.5M)(312.7M)(272.5M)(245.3M)(233.0M)
Common Stock Total Equity571K575K580K583K670.5K417.0K
Common Stock580K583K586K588K676.2K435.6K
Other Assets145.6M240.8M202.3M261.3M300.5M315.5M
Good Will1.9B1.9B1.9B2.8B3.2B3.3B
Property Plant Equipment535.7M592.1M630.5M665.8M765.7M384.1M
Other Liab221.6M172.6M160.0M315.2M362.5M380.6M
Long Term Debt1.2B643.4M765.3M1.4B1.6B1.7B
Current Deferred Revenue98.6M109.6M108.7M138.1M158.8M166.7M
Net Tangible Assets158.5M565.2M1.1B807.3M726.5M632.7M
Long Term Debt Total1.3B1.2B643.4M765.3M880.1M737.7M
Capital Surpluse1.5B1.6B1.6B1.7B1.9B1.5B

Currently Active Assets on Macroaxis

When determining whether ResMed Inc is a strong investment it is important to analyze ResMed's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact ResMed's future performance. For an informed investment choice regarding ResMed Stock, refer to the following important reports:
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in ResMed Inc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in population.
You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.

Complementary Tools for ResMed Stock analysis

When running ResMed's price analysis, check to measure ResMed's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ResMed is operating at the current time. Most of ResMed's value examination focuses on studying past and present price action to predict the probability of ResMed's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ResMed's price. Additionally, you may evaluate how the addition of ResMed to your portfolios can decrease your overall portfolio volatility.
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Is ResMed's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of ResMed. If investors know ResMed will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about ResMed listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.07)
Dividend Share
1.84
Earnings Share
6.04
Revenue Per Share
30.633
Quarterly Revenue Growth
0.125
The market value of ResMed Inc is measured differently than its book value, which is the value of ResMed that is recorded on the company's balance sheet. Investors also form their own opinion of ResMed's value that differs from its market value or its book value, called intrinsic value, which is ResMed's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because ResMed's market value can be influenced by many factors that don't directly affect ResMed's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between ResMed's value and its price as these two are different measures arrived at by different means. Investors typically determine if ResMed is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ResMed's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.